Credit Suisse Maintains Neutral on Diplomat Pharmacy, Lowers Price Target to $5

Credit Suisse maintains Diplomat Pharmacy (NYSE:DPLO) with a Neutral and lowers the price target from $6 to $5.

Benzinga · 11/18/2019 15:02

Credit Suisse maintains Diplomat Pharmacy (NYSE:DPLO) with a Neutral and lowers the price target from $6 to $5.